NASDAQ: KIN       Kindred Biosciences
Last Price Today's Change   Day's Range   Trading Volume
4.48   +0.03 (0.67%)  4.33 - 4.63  19,265


Avg Volume (4 weeks):257,470
4 Weeks Range:4.08 - 5.21
4 Weeks Price Volatility (%):
52 Weeks Range:3.105 - 11.93
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Kindred Biosciences Inc is a US-based development-stage biopharmaceutical company which focuses on developing medicines for pets. Its lead products candidates are the intravenous (IV) form of Zimeta which is a dipyrone injection for the control of pyrexia in horses and Mirataz which is a mirtazapine transdermal ointment for the management of weight loss in cats. The product pipeline of the company consists of small molecules and biologics for a range of indications in dogs, cats, and horses, with focus near-term on equine small molecule products and canine and feline biologics products.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3413  2639  591  3249 

Top 10 Active Counters
 LK 1.38+1.38 
 WPX 9.43+0.48 
 CTRM 0.395-0.03 
 ADMP 1.875+0.605 
 SNDL 0.625-0.036 
 HTZ 0.00-1.75 
 GPOR 0.1380.00 
 OBLN 6.91+1.72 
 F 11.47-0.06 
 AMTD 39.97-0.85